Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Gross Margin: 2017-2019

Historic Gross Margin for Neurocrine Biosciences (NBIX) over the last 3 years, with Dec 2019 value amounting to 99.06%.

  • Neurocrine Biosciences' Gross Margin fell 37.00% to 98.58% in Q3 2021 from the same period last year, while for Sep 2021 it was 99.78%, marking a year-over-year increase of 72.00%. This contributed to the annual value of 99.06% for FY2019, which is 14.00% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Gross Margin of 99.06% as of FY2019, which was up 0.14% from 98.92% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Gross Margin ranged from a high of 99.06% in FY2019 and a low of 91.64% during FY2017.
  • For the 3-year period, Neurocrine Biosciences' Gross Margin averaged around 96.54%, with its median value being 98.92% (2018).
  • Data for Neurocrine Biosciences' Gross Margin shows a peak YoY surged of 728bps (in 2018) over the last 5 years.
  • Yearly analysis of 3 years shows Neurocrine Biosciences' Gross Margin stood at 91.64% in 2017, then surged by 728bps to 98.92% in 2018, then climbed by 14bps to 99.06% in 2019.